Vanderbilt University Medical Center's Academy for Excellence in Education has elected 13 new members for 2023.

A Vanderbilt study of genetic risks for cognitive impairment later in life uses data from 32,426 research participants ages 60 and older to elaborate these risks across sex and across the intersection of sex and race.

Many low-risk patients with a penicillin allergy were able to have their penicillin allergy label removed through a simple procedure known as “direct oral challenge” as part of a world-first multicenter randomized control trial known as the Penicillin Allergy Clinical Decision Rule (PALACE) study.

Vanderbilt's Melissa Straub Hogan, MD, has been named to the 2023 American Society for Clinical Pathology 40 Under Forty list.

A recent Vanderbilt study is one of the first to use statistical and population-based methods to understand comorbidities associated with developmental language disorder at a population level.

In partnership with the Universidad Peruana Cayetano Heredia (UPCH) and the Instituto de Investigacion Nutricional (IIN), the Vanderbilt Institute for Global Health (VIGH) has received $1.2 million for a five-year training grant funded by the Fogarty International Center to establish the Peru-Vanderbilt Prevention through Vaccination Training program.

Together with the Vanderbilt Kennedy Center and ACM Lifting Lives, SENSE Theatre recently presented a two-night performance of the play Circus del Sé, written by Blythe Corbett, PhD, James G. Blakemore Professor of Psychiatry and Behavioral Sciences.